Tyra Biosciences, Inc. (TYRA)
35.56
+0.44
(+1.25%)
USD |
NASDAQ |
Apr 17, 16:00
35.50
-0.06
(-0.17%)
After-Hours: 06:49
Tyra Biosciences SG&A Expense (Quarterly) : 8.33M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 12.53M |
| Entrada Therapeutics, Inc. | 9.55M |
| BioMarin Pharmaceutical, Inc. | 446.21M |
| Ionis Pharmaceuticals, Inc. | 130.00M |
| Agios Pharmaceuticals, Inc. | 51.61M |